Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
Daniela Berg(Christian-Albrechts-Universität zu Kiel), Günther Deuschl(Christian-Albrechts-Universität zu Kiel), John Hardy(UK Dementia Research Institute), Ronald B. Postuma(Montreal Neurological Institute and Hospital), Bastiaan R. Bloem(Radboud University Nijmegen), Glenda M. Halliday(The University of Sydney), Werner Poewe(Innsbruck Medical University), Wolfgang H. Oertel(Philipps University of Marburg), Christopher G. Goetz(St. Luke's Hospital), José Á. Obeso(Instituto de Salud Carlos III), Thomas Gasser(Hertie Institute for Clinical Brain Research), Matthew Stern(Penn Center for AIDS Research), C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Kenneth Marek(University of Pennsylvania), Bruno Dubois(Université de Lille), Anthony E. Lang(University of Toronto), Piu Chan(Capital Medical University), Irene Litvan(University of California, San Diego)
Cited by 497
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k